UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by RNC Capital Management LLC

RNC Capital Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,701 shares of the healthcare conglomerate’s stock after acquiring an additional 161 shares during the quarter. RNC Capital Management LLC’s holdings in UnitedHealth Group were worth $7,740,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Columbia Trust Co 01012016 lifted its holdings in UnitedHealth Group by 13.0% in the fourth quarter. Columbia Trust Co 01012016 now owns 5,254 shares of the healthcare conglomerate’s stock valued at $2,766,000 after acquiring an additional 604 shares during the period. San Luis Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 5.6% in the fourth quarter. San Luis Wealth Advisors LLC now owns 6,451 shares of the healthcare conglomerate’s stock valued at $3,396,000 after acquiring an additional 340 shares during the period. Canvas Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 6.7% in the fourth quarter. Canvas Wealth Advisors LLC now owns 795 shares of the healthcare conglomerate’s stock valued at $415,000 after buying an additional 50 shares in the last quarter. jvl associates llc purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $229,000. Finally, PFG Investments LLC increased its position in shares of UnitedHealth Group by 6.4% in the fourth quarter. PFG Investments LLC now owns 6,042 shares of the healthcare conglomerate’s stock valued at $3,181,000 after buying an additional 364 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $493.14 on Thursday. The business’s 50-day simple moving average is $503.73 and its 200-day simple moving average is $518.79. The firm has a market capitalization of $454.64 billion, a P/E ratio of 20.69, a P/E/G ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same period in the previous year, the company posted $5.34 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Analyst Ratings Changes

A number of analysts recently commented on UNH shares. Stephens reiterated an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Bank of America reiterated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. HSBC reiterated a “reduce” rating and set a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Piper Sandler decreased their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.